Life Sciences
Life Sciences Summit 2010
Call for emerging companies and innovators to present Emerging Company and Innovator’s Showcase Call for Presenters: We are pleased to announce our call for emerging companies and innovators that would like to present in the Emerging Company and Innovators Showcase at the Life Sciences Summit 2010. The Emerging Company & Innovator’s Showcase will feature 15-minute [...]
INVITATION ALUMNI BREAKFAST SPEAKER SERIES
The University of Ottawa Telfer School of Management is pleased to invite you to the next BioTech themed breakfast. James Pelot Chief Financial Officer, ArcticDX Discussing: “From Bench to Box – a genetic testing biotech start-up journey” James Pelot will speak about evolution of genetic testing over the last ten [...]
International Swine Flu Conference, November 23-24, 2009 in Toronto, Canada
Top leaders and key decision-makers of major companies representing a broad range of industries will meet with distinguished scientists, public health officials, law enforcers, first responders, and other experts to discuss pandemic prevention, preparedness, response and recovery at the 1st International Swine Flu Conference. At the International Swine Flu Conference, attendees will be able to [...]
University of Ottawa researchers elected to the Royal Society of Canada
OTTAWA, September 28, 2009 — Xiaoyi Bao and Annie Brisset, researchers at the University of Ottawa, have been elected fellows of the Royal Society of Canada (RSC) in recognition of their exceptional achievements in the areas of sciences and arts and humanities, respectively. Xiaoyi Bao, a professor in the Department of Physics at the Faculty [...]
The $78.3 Billion Canadian Bio-based Economy
Biotechnology is driving an economic shift to a broader “bio-based economy” which integrates biologic products and technologies, derived from renewable resources into new sustainable production and manufacturing processes. Canada’s bio-based economy is valued at 78.3 billion dollars. At 6.4 percent of the GDP, this footprint is larger than the automotive and aerospace sectors respectively. The [...]
BIOTECanada’s Biotechnology Timeline
Beginning in 8,000 BC with the domestication of plant crops and livestock, the Biotechnology Timeline will take you through the decades of biotechnology development worldwide, and in Canada. From Quebec City and Jean Talon’s brewery using yeast and fermentation technology in the 1660s, to the first reference of biotechnology in print in 1919, to Canada’s [...]
Biotechnology Partnering Initiative – BioWindhover’s Therapeutics Area Partnering Conference
BIOTECanada and the Consulate General of Canada in Boston would like to invite you to participate in the upcoming Biotechnology Partnering Initiative, which is open to Canadian biotechnology companies and takes place in partnership with BioWindhover’s Therapeutics Area Partnering Conference http://www.tapartnerships.com/content/Main.aspx in Boston, November 17-19, 2009. The Initiative is limited to 10 Canadian biotechnology companies [...]
Exhibition Opporunity at LifeScience Alley in Minneapolis, Minnesota, December 9, 2009
Dear Company Representative: I am writing to advise you of an important conference and trade show in Minneapolis, Minnesota, December 9, 2009, hosted by LifeScience Alley. LifeScience Alley is a non profit trade association of life science industry professionals, located in Minneapolis. The 8th Annual Conference and Expo is expected to attract over 1,600 attendees [...]
The University of Ottawa hosts important conference on Genetically Modified Organisms
OTTAWA, September 21, 2009 — The University of Ottawa will host an important conference on Genetically Modified Organisms (GMO), organized by the Royal Society of Canada and the Science Academy of the French Institute, on September 22 and 23, 2009. During this conference, researchers from Canada and France will be discussing the use of genetically [...]
University of Ottawa study identifies a potential new treatment for Duchenne Muscular Dystrophy
OTTAWA, September 21, 2009 — A study led by Dr. Bernard Jasmin, Department of Cellular and Molecular Medicine, Faculty of Medecine of the University of Ottawa and his colleagues, identified a novel therapeutic approach that could potentially counteract the effects of Duchenne Muscular Dystrophy (DMD), a severe and prevalent inherited genetic disorder. In patients, DMD [...]